Investment Thesis
Investing in life-saving science in the Nordics and Baltics, focusing on early-stage biotech and digital health companies that address unmet medical needs with global potential. The fund leverages the region's strong scientific and technological capabilities to drive impactful healthcare solutions.
Stage Focus
Pre-seed to Series A
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Early-stage companies developing life-saving or life-altering products for unmet medical needs with global potential
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€250,000 - €90,000,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
